STXS · Stereotaxis Inc. Common Stock
View on chartInsiders & Stakes
| Arun Swarup Menawat Director | ▲ Buy | Grant | 1,035,560 Shares held | 7/1/2026 | View profile |
| Fischel Nathan Director | ▲ Buy | Grant | 720,775 Shares held | 7/1/2026 | View profile |
| Levin Ross B Director | ▲ Buy | Grant | 621,248 Shares held | 7/1/2026 | View profile |
| Benfer David Director | ▲ Buy | Grant | 558,975 Shares held | 7/1/2026 | View profile |
| MESSEY ROBERT J Director | ▲ Buy | Grant | 518,402 Shares held | 1/2/2024 | View profile |
| Myriam Curet Director | ▲ Buy | Grant | 435,161 Shares held | 7/1/2026 | View profile |
| SHAMIR NACHUM Director | ▲ Buy | Grant | 179,327 Shares held | 7/1/2026 | View profile |
| Isaac Paul J | ▲ Buy | Open Market | 97,299 Shares held | 11/17/2025 | View profile |
Transaction History
| SHAMIR NACHUM | ▲ Buy | Grant | 43,103 | $0 | 7/1/2026 |
| Benfer David | ▲ Buy | Grant | 43,103 | $0 | 7/1/2026 |
| Levin Ross B | ▲ Buy | Grant | 43,103 | $0 | 7/1/2026 |
| Myriam Curet | ▲ Buy | Grant | 43,103 | $0 | 7/1/2026 |
| Fischel Nathan | ▲ Buy | Grant | 43,103 | $0 | 7/1/2026 |
| Arun Swarup Menawat | ▲ Buy | Grant | 43,103 | $0 | 7/1/2026 |
| Arun Swarup Menawat | ▲ Buy | Grant | 46,948 | $0 | 1/2/2026 |
| Benfer David | ▲ Buy | Grant | 46,948 | $0 | 1/2/2026 |
| Myriam Curet | ▲ Buy | Grant | 46,948 | $0 | 1/2/2026 |
| Fischel Nathan | ▲ Buy | Grant | 46,948 | $0 | 1/2/2026 |
| Levin Ross B | ▲ Buy | Grant | 46,948 | $0 | 1/2/2026 |
| SHAMIR NACHUM | ▲ Buy | Grant | 46,948 | $0 | 1/2/2026 |
| Isaac Paul J | ▲ Buy | Open Market | 10,000 | $22K | 11/17/2025 |
| Isaac Paul J | ▲ Buy | Open Market | 20,000 | $45K | 11/14/2025 |
| Fischel Nathan | ▲ Buy | Grant | 43,668 | $0 | 7/1/2025 |
| Levin Ross B | ▲ Buy | Grant | 43,668 | $0 | 7/1/2025 |
| Benfer David | ▲ Buy | Grant | 43,668 | $0 | 7/1/2025 |
| Myriam Curet | ▲ Buy | Grant | 43,668 | $0 | 7/1/2025 |
| Arun Swarup Menawat | ▲ Buy | Grant | 43,668 | $0 | 7/1/2025 |
| SHAMIR NACHUM | ▲ Buy | Grant | 43,668 | $0 | 7/1/2025 |
| Isaac Paul J | ▲ Buy | Open Market | 38,000 | $69K | 3/10/2025 |
| Isaac Paul J | ▲ Buy | Open Market | 1,489 | $3K | 3/7/2025 |
| Isaac Paul J | ▲ Buy | Open Market | 23,299 | $42K | 3/6/2025 |
| Levin Ross B | ▲ Buy | Grant | 56,497 | $0 | 1/2/2025 |
| Arun Swarup Menawat | ▲ Buy | Grant | 56,497 | $0 | 1/2/2025 |
| Fischel Nathan | ▲ Buy | Grant | 56,497 | $0 | 1/2/2025 |
| Benfer David | ▲ Buy | Grant | 56,497 | $0 | 1/2/2025 |
| Myriam Curet | ▲ Buy | Grant | 56,497 | $0 | 1/2/2025 |
| SHAMIR NACHUM | ▲ Buy | Grant | 45,608 | $0 | 1/2/2025 |
| Isaac Paul J | ▲ Buy | Open Market | 442 | $831 | 8/20/2024 |
| Isaac Paul J | ▲ Buy | Open Market | 812 | $2K | 8/19/2024 |
| Isaac Paul J | ▲ Buy | Open Market | 8,095 | $15K | 8/15/2024 |
| Benfer David | ▲ Buy | Grant | 53,475 | $0 | 7/1/2024 |
| Fischel Nathan | ▲ Buy | Grant | 53,475 | $0 | 7/1/2024 |
| Levin Ross B | ▲ Buy | Grant | 53,475 | $0 | 7/1/2024 |
| Arun Swarup Menawat | ▲ Buy | Grant | 53,475 | $0 | 7/1/2024 |
| Myriam Curet | ▲ Buy | Grant | 53,475 | $0 | 7/1/2024 |
| Isaac Paul J | ▲ Buy | Open Market | 7,000 | $13K | 6/14/2024 |
| Isaac Paul J | ▲ Buy | Open Market | 1,000 | $2K | 5/31/2024 |
| Isaac Paul J | ▲ Buy | Open Market | 3,026 | $6K | 5/29/2024 |
| Isaac Paul J | ▲ Buy | Open Market | 6,000 | $11K | 5/28/2024 |
| Fischel Nathan | ▲ Buy | Grant | 64,935 | $0 | 1/2/2024 |
| MESSEY ROBERT J | ▲ Buy | Grant | 64,935 | $0 | 1/2/2024 |
| Myriam Curet | ▲ Buy | Grant | 64,935 | $0 | 1/2/2024 |
| Benfer David | ▲ Buy | Grant | 64,935 | $0 | 1/2/2024 |
| Levin Ross B | ▲ Buy | Grant | 64,935 | $0 | 1/2/2024 |
| Arun Swarup Menawat | ▲ Buy | Grant | 64,935 | $0 | 1/2/2024 |
| Isaac Paul J | ▲ Buy | Open Market | 11,060 | $19K | 12/15/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 2,808 | $4K | 11/30/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 18 | $27 | 11/22/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 6,000 | $9K | 11/21/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 6,000 | $9K | 11/20/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 6,000 | $9K | 11/17/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 15,000 | $23K | 11/16/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 20,000 | $29K | 11/15/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 10,000 | $15K | 11/14/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 10,000 | $14K | 11/13/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 16,000 | $26K | 9/15/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 7,168 | $12K | 9/14/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 6,305 | $11K | 9/13/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 1,200 | $2K | 9/12/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 10,000 | $17K | 8/30/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 6,739 | $11K | 8/29/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 9,311 | $16K | 8/28/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 5,000 | $9K | 8/25/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 4,000 | $7K | 8/24/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 6,000 | $11K | 8/22/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 6,198 | $10K | 8/21/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 6,000 | $9K | 8/17/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 4,685 | $7K | 8/16/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 16,687 | $25K | 8/15/2023 |
| Isaac Paul J | ▲ Buy | Open Market | 400 | $604 | 8/14/2023 |
| Fischel Nathan | ▲ Buy | Grant | 47,619 | $0 | 7/3/2023 |
| Benfer David | ▲ Buy | Grant | 47,619 | $0 | 7/3/2023 |
| Myriam Curet | ▲ Buy | Grant | 47,619 | $0 | 7/3/2023 |
| MESSEY ROBERT J | ▲ Buy | Grant | 47,619 | $0 | 7/3/2023 |
| Levin Ross B | ▲ Buy | Grant | 47,619 | $0 | 7/3/2023 |
| Arun Swarup Menawat | ▲ Buy | Grant | 47,619 | $0 | 7/3/2023 |
| Myriam Curet | ▲ Buy | Grant | 54,054 | $0 | 1/3/2023 |
| MESSEY ROBERT J | ▲ Buy | Grant | 54,054 | $0 | 1/3/2023 |
| Fischel Nathan | ▲ Buy | Grant | 54,054 | $0 | 1/3/2023 |
| Arun Swarup Menawat | ▲ Buy | Grant | 54,054 | $0 | 1/3/2023 |
| Benfer David | ▲ Buy | Grant | 54,054 | $0 | 1/3/2023 |
| Levin Ross B | ▲ Buy | Grant | 54,054 | $0 | 1/3/2023 |
| Myriam Curet | ▲ Buy | Grant | 15,527 | $0 | 7/1/2022 |
| Fischel Nathan | ▲ Buy | Grant | 15,527 | $0 | 7/1/2022 |
| MESSEY ROBERT J | ▲ Buy | Grant | 15,527 | $0 | 7/1/2022 |
| Benfer David | ▲ Buy | Grant | 15,527 | $0 | 7/1/2022 |
| Levin Ross B | ▲ Buy | Grant | 15,527 | $0 | 7/1/2022 |
| Arun Swarup Menawat | ▲ Buy | Grant | 15,527 | $0 | 7/1/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 2,100 | $4K | 5/26/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 12,200 | $22K | 5/25/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 9,992 | $18K | 5/24/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 4,300 | $8K | 5/23/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 28,440 | $51K | 5/20/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 14,823 | $27K | 5/19/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 26,287 | $48K | 5/18/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 19,238 | $35K | 5/16/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 9,500 | $17K | 5/16/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 70,000 | $130K | 5/13/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 35,000 | $66K | 5/13/2022 |
| Isaac Paul J | ▲ Buy | Open Market | 51,751 | $91K | 5/12/2022 |
| Fischel Nathan | ▲ Buy | Grant | 10,449 | $0 | 1/4/2022 |
| Arun Swarup Menawat | ▲ Buy | Grant | 10,449 | $0 | 1/4/2022 |
| MESSEY ROBERT J | ▲ Buy | Grant | 10,449 | $0 | 1/4/2022 |
| Levin Ross B | ▲ Buy | Grant | 10,449 | $0 | 1/4/2022 |
| Benfer David | ▲ Buy | Grant | 10,449 | $0 | 1/4/2022 |
| Myriam Curet | ▲ Buy | Grant | 9,335 | $0 | 1/4/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
No recent news for STXS
There are no new developments for Stereotaxis Inc. in the past week. The company continues to trade near its 12‑month low, with an RSI of 22.8 indicating oversold conditions. The 52‑week range remains $1.09 to $3.59, and analysts maintain a target of $3.00.
No recent news for STXS. There are no new developments for Stereotaxis Inc. in the past week. The company continues to trade near its 12‑month low, with an RSI of 22.8 indicating oversold conditions. The 52‑week range remains $1.09 to $3.59, and analysts maintain a target of $3.00.